Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-003708
Filing Date
2018-03-21
Accepted
2018-03-21 16:16:37
Documents
77
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1692592
2 image_001.jpg GRAPHIC 21238
3 ex23-1.htm EX-23.1 4668
4 ex31-1.htm EX-31.1 11196
5 ex31-2.htm EX-31.2 11028
6 ex32-1.htm EX-32.1 11955
  Complete submission text file 0001493152-18-003708.txt   5210268

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cocp-20171231.xml EX-101.INS 805170
8 XBRL SCHEMA FILE cocp-20171231.xsd EX-101.SCH 47044
9 XBRL CALCULATION FILE cocp-20171231_cal.xml EX-101.CAL 56504
10 XBRL DEFINITION FILE cocp-20171231_def.xml EX-101.DEF 181515
11 XBRL LABEL FILE cocp-20171231_lab.xml EX-101.LAB 327281
12 XBRL PRESENTATION FILE cocp-20171231_pre.xml EX-101.PRE 281655
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38418 | Film No.: 18704604
SIC: 2834 Pharmaceutical Preparations